- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05862532
Gut Microbiome and Blood Markers After Habitual Herbal Tea Consumption (SRTT)
TeTrimTeas: Gut Microbiome and Blood Lipid Markers After Habitual Herbal Tea Consumption
TeTrimTeas intends is to establish a long-term cooperative with local growers and producers who will become partners in the business, with profit share to local growers and producers. The overall aim of the company is to produce quality, science-based botanical/herbal teas to improve health and wellbeing, growing as many of the ingredients locally and organically, to reduce food-to-fork miles within the decarbonisation and sustainability agendas in Wales.
TeTrimTeas have created herbal green tea blends, improving on existing Chinese formulation, and would like to test it as 'health tea'. The recruited cohort will be randomised into one of three intervention teas (green tea control, senna herbal mix and rhubarb root herbal mix). They would like to explore if consumption of the teas for 21 days has an impact on digestion and potentially help control weight gain.
Aberystwyth University will use high resolution metabolomics to investigate the chemical composition of capillary blood samples, in particular the short chain fatty acids. They will also assess lipid composition in capillary bloods and the microbiome of stools. Diet data, stool consistency and anthropometric measurements will be collected pre and post intervention. Results will advance product development and data would be used in grant applications into the health benefits of the herbal teas.
Study Overview
Status
Conditions
Detailed Description
TeTrimTeas has created herbal green tea blends, improving on existing Chinese formulation, and would like to test it as 'health tea'. The recruited cohort will be randomised into one of three intervention teas (green tea control, senna herbal mix and rhubarb root herbal mix). This will be double blinded so neither the participant nor the researcher will know what group they have been allocated into. Information can be disclosed at the end of the study. Participants will come to WARU or Trimsaran Community Health Centre for induction and study visits.
The experimental sequence
'Diet-monitoring' period (two days before the study)
Prior to the experimental session it is important that all participants undergo a period where foods are recorded. This will help the researchers interpret any results after consumption of the test/control food. The researchers would ask them to refrain from taking any over-the-counter medication (such as ibuprofen, paracetamol, aspirin, cough/ cold remedies) or herbal supplements, and to let us know if they find that it is necessary to take any such medication during the trial.
Experimental session- 21 days
Morning: Participants will come to WARU or Trimsaran Community Health Centre for their pre-organised timeslot to allow researchers to collect a fasted capillary (fingerpick) blood samples and stool sample. They may consume their breakfast after their visit. They will also collect their tea bags. Researchers will also take participants weight and height and collect diet data (PDQS) and stool scores (Bristol Stool scale).
Over 21 days: the researchers would ask the participants to consume a cup of tea after their last meal/snack of the day (post 6pm) daily, for 21 days. The researchers would ask them not to consume anything after the tea. In a cup/mug the researchers would ask them to place a 2.5g tea bag and add 190ml of hot water (80-100◦C) and stir clockwise 10 consecutive times to allow for optimal infusion and then allow to brew for 5 minutes, before removal.
After the experimental period:
Before their final visit (or at their final visit): the researchers would like participants to fill in another food questionnaire and a stool scale.
Morning of their final visit. The researchers would ask the participant to come to WARU or Trimsaran Community Health Centre for their pre-organised timeslot to allow us to collect a fasted capillary (fingerpick) blood samples and stool sample. The researchers will also take their weight and height. They may consume their breakfast after their visit. Afterwards, they can go back to their 'normal' eating pattern.
Study Type
Enrollment (Actual)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
Ceredigion
-
Aberystwyth, Ceredigion, United Kingdom, SY23 3FD
- Well-being and Health Assessment Research Unit (WARU)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Consenting adults >18 y Age
- Commit to fasting capillary blood collection
- Commit to stool sampling collection
- Able to refrain from taking any over-the-counter medication or herbal supplements during the diet monitoring and experimental periods.
- Able to prepare and consume the tea during the experimental days, after the last meal/snack of the day and not to consume anything afterwards
- Fill in diet diaries, FFQ and stool ranking
- Able to inform the researcher if any antibiotics or heavy alcohol is consumed over the intervention period
Exclusion Criteria
- Showing (or anyone within the household) any COVID-19 symptoms (see COVID-19 basic health screen)*
- Higher risk or vulnerable from coronavirus or live with someone at a higher risk of a severe illness from COVID-19 (over 70, undergoing cancer treatment, high risk of getting infections).
- Had a letter from the NHS advising you to shield (isolate)
- Had been at risk of exposure to COVID-19 such as travel, contact with someone with COVID-19, been exposed to the virus, or has been asked to self-isolate by the track and trace system.
- Serious health conditions that require daily long-term medications (including immunosuppressants)
- A history or current diabetes, lung issues, gut inflammation (Crohns, IBD), digestive disorders
- Diagnosed with a serious health condition within the last 12 months
- Pregnant
- Play sports at a high level (more than 7h/week or 1h/day)
- Smoking
- consume high dose of alcohol > 21 unit per week for men and > 14 units per week for women
Food allergy /food intolerance/ eating disorder or are on a specially prescribed diet
- If the potential participant has had COVID-19 previously (and are fully recovered and not within isolation) then they are eligible to join the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Welsh Herbal tea with Senna
Welsh Herbal tea with green tea and Senna
|
TeTrimTeas welsh Herbal tea with green tea and senna
|
Experimental: Welsh Herbal tea with rhubarb root
Welsh Herbal tea with green tea and rhubarb root
|
TeTrimTeas welsh Herbal tea with green tea and rhubarb root
|
Active Comparator: Green tea
Dartmoor green tea
|
TeTrimTeas welsh Herbal tea with green tea
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in total plasma Cholesterol after the rhubarb root tea
Time Frame: Decrease from Baseline plasma Cholesterol after 21 days
|
Change in total Cholesterol (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Decrease from Baseline plasma Cholesterol after 21 days
|
Change in total plasma Cholesterol after the rhubarb root tea
Time Frame: Decrease from total Cholesterol plasma after the rhubarb root tea when compared with senna tea plasma Cholesterol after 21 days
|
Change in total Cholesterol (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Decrease from total Cholesterol plasma after the rhubarb root tea when compared with senna tea plasma Cholesterol after 21 days
|
Change in total plasma Cholesterol after the rhubarb root tea
Time Frame: Decrease from total Cholesterol plasma after the rhubarb root tea when compared with green tea plasma Cholesterol after 21 days
|
Change in total Cholesterol (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Decrease from total Cholesterol plasma after the rhubarb root tea when compared with green tea plasma Cholesterol after 21 days
|
Change in total plasma Cholesterol after the senna tea
Time Frame: Decrease from Baseline plasma Cholesterol after 21 days
|
Change in total Cholesterol (mmol/L) after the senna tea measured in capillary bloods using AFINION S100
|
Decrease from Baseline plasma Cholesterol after 21 days
|
Change in total plasma Cholesterol after the green tea
Time Frame: Decrease from Baseline plasma Cholesterol after 21 days
|
Change in total Cholesterol (mmol/L) after the green tea measured in capillary bloods using AFINION S100
|
Decrease from Baseline plasma Cholesterol after 21 days
|
Change in plasma Low density lipoprotein cholesterol (LDL-C) after the rhubarb root tea
Time Frame: Decrease from Baseline plasma Low density lipoprotein cholesterol (LDL-C) after 21 days
|
Change in Low density lipoprotein cholesterol (LDL-C) (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Decrease from Baseline plasma Low density lipoprotein cholesterol (LDL-C) after 21 days
|
Change in plasma Low density lipoprotein cholesterol (LDL-C) after the rhubarb root tea
Time Frame: Decrease from plasma Low density lipoprotein cholesterol (LDL-C) after the rhubarb root tea when compared with senna tea plasma Low density lipoprotein cholesterol (LDL-C) after 21 days
|
Change in Low density lipoprotein cholesterol (LDL-C) (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Decrease from plasma Low density lipoprotein cholesterol (LDL-C) after the rhubarb root tea when compared with senna tea plasma Low density lipoprotein cholesterol (LDL-C) after 21 days
|
Change in plasma Low density lipoprotein cholesterol (LDL-C) after the rhubarb root tea
Time Frame: Decrease from plasma Low density lipoprotein cholesterol (LDL-C) after the rhubarb root tea when compared with green tea plasma Low density lipoprotein cholesterol (LDL-C) after 21 days
|
Change in Low density lipoprotein cholesterol (LDL-C) (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Decrease from plasma Low density lipoprotein cholesterol (LDL-C) after the rhubarb root tea when compared with green tea plasma Low density lipoprotein cholesterol (LDL-C) after 21 days
|
Change in plasma Low density lipoprotein cholesterol (LDL-C) after the senna tea
Time Frame: Decrease from Baseline plasma Low density lipoprotein cholesterol (LDL-C) after 21 days
|
Change in Low density lipoprotein cholesterol (LDL-C) (mmol/L) after the senna tea measured in capillary bloods using AFINION S100
|
Decrease from Baseline plasma Low density lipoprotein cholesterol (LDL-C) after 21 days
|
Change in plasma Low density lipoprotein cholesterol (LDL-C) after the green tea
Time Frame: Decrease from Baseline plasma Low density lipoprotein cholesterol (LDL-C) after 21 days
|
Change in Low density lipoprotein cholesterol (LDL-C) (mmol/L) after the green tea measured in capillary bloods using AFINION S100
|
Decrease from Baseline plasma Low density lipoprotein cholesterol (LDL-C) after 21 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in plasma High-Density Lipoprotein cholesterol (HDL-C) after the rhubarb root tea
Time Frame: Increase from Baseline plasma High-Density Lipoprotein cholesterol (HDL-C) after 21 days
|
Change in High-Density Lipoprotein cholesterol (HDL-C) (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Increase from Baseline plasma High-Density Lipoprotein cholesterol (HDL-C) after 21 days
|
Change in plasma High-Density Lipoprotein cholesterol (HDL-C) after the rhubarb root tea
Time Frame: Increase of plasma High-Density Lipoprotein cholesterol (HDL-C) after Rhubarb root tea when compared with senna tea plasma High-Density Lipoprotein cholesterol (HDL-C) after 21 days
|
Change in High-Density Lipoprotein cholesterol (HDL-C) (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Increase of plasma High-Density Lipoprotein cholesterol (HDL-C) after Rhubarb root tea when compared with senna tea plasma High-Density Lipoprotein cholesterol (HDL-C) after 21 days
|
Change in plasma High-Density Lipoprotein cholesterol (HDL-C) after the rhubarb root tea
Time Frame: Increase of plasma High-Density Lipoprotein cholesterol (HDL-C) after Rhubarb root tea when compared with green tea plasma High-Density Lipoprotein cholesterol (HDL-C) after 21 days
|
Change in High-Density Lipoprotein cholesterol (HDL-C) (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Increase of plasma High-Density Lipoprotein cholesterol (HDL-C) after Rhubarb root tea when compared with green tea plasma High-Density Lipoprotein cholesterol (HDL-C) after 21 days
|
Change in plasma High-Density Lipoprotein cholesterol (HDL-C) after the senna tea
Time Frame: Increase from Baseline plasma High-Density Lipoprotein cholesterol (HDL-C) after 21 days
|
Change in High-Density Lipoprotein cholesterol (HDL-C) (mmol/L) after the senna tea measured in capillary bloods using AFINION S100
|
Increase from Baseline plasma High-Density Lipoprotein cholesterol (HDL-C) after 21 days
|
Change in plasma High-Density Lipoprotein cholesterol (HDL-C) after the green tea
Time Frame: Increase from Baseline plasma High-Density Lipoprotein cholesterol (HDL-C) after 21 days
|
Change in High-Density Lipoprotein cholesterol (HDL-C) (mmol/L) after the green tea measured in capillary bloods using AFINION S100
|
Increase from Baseline plasma High-Density Lipoprotein cholesterol (HDL-C) after 21 days
|
Change in plasma Triglycerides after the rhubarb root tea
Time Frame: Decrease from Baseline plasma Triglycerides after 21 days
|
Change in Triglycerides (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Decrease from Baseline plasma Triglycerides after 21 days
|
Change in plasma Triglycerides after the senna tea
Time Frame: Decrease from senna tea plasma Triglycerides after 21 days
|
Change in Triglycerides (mmol/L) after the senna measured in capillary bloods using AFINION S100
|
Decrease from senna tea plasma Triglycerides after 21 days
|
Change in plasma Triglycerides after the green tea
Time Frame: Decrease from green tea plasma Triglycerides after 21 days
|
Change in Triglycerides (mmol/L) after the green tea measured in capillary bloods using AFINION S100
|
Decrease from green tea plasma Triglycerides after 21 days
|
Change in plasma Triglycerides after the rhubarb root tea
Time Frame: Decrease from rhubarb root plasma Triglycerides after 21 days when compared with senna tea plasma Triglycerides after 21 days
|
Change in Triglycerides (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Decrease from rhubarb root plasma Triglycerides after 21 days when compared with senna tea plasma Triglycerides after 21 days
|
Change in plasma Triglycerides after the rhubarb root tea
Time Frame: Decrease from rhubarb root plasma Triglycerides after 21 days when compared with green tea plasma Triglycerides after 21 days
|
Change in Triglycerides (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Decrease from rhubarb root plasma Triglycerides after 21 days when compared with green tea plasma Triglycerides after 21 days
|
Change in plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after the rhubarb root tea
Time Frame: Decrease from Baseline plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after 21 days
|
Change in non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Decrease from Baseline plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after 21 days
|
Change in plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after the senna tea
Time Frame: Decrease from senna tea plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after 21 days
|
Change in non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) (mmol/L) after the senna tea measured in capillary bloods using AFINION S100
|
Decrease from senna tea plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after 21 days
|
Change in plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after the green tea
Time Frame: Decrease from green tea plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after 21 days
|
Change in non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) (mmol/L) after the green tea measured in capillary bloods using AFINION S100
|
Decrease from green tea plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after 21 days
|
Change in plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after the rhubarb root tea
Time Frame: Decrease of plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after 21 days of the rhubarb root tea when compared with 21 days of the senna tea
|
Change in non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) (mmol/L) after the after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Decrease of plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after 21 days of the rhubarb root tea when compared with 21 days of the senna tea
|
Change in plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after the rhubarb root tea
Time Frame: Decrease of plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after 21 days of the rhubarb root tea when compared with 21 days of the green tea
|
Change in non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) (mmol/L) after the rhubarb root tea measured in capillary bloods using AFINION S100
|
Decrease of plasma non- high-density lipoprotein cholesterol (total cholesterol - high-density lipoprotein cholesterol) after 21 days of the rhubarb root tea when compared with 21 days of the green tea
|
Diet choices change measured using the Prime Diet Quality Score
Time Frame: Increased score from baseline Prime Diet Quality Score at 21 days after the Rhubarb root tea
|
Measured using the Prime Diet Quality Score.
The Prime Diet Quality Score (PDQS) measures intake of the 22 component foods/food groups over the last 30 days with seven possible responses for each component ranging from "once a month or less" to "≥ 2 times/day."
Scores are then summed to create a PDQS total diet quality score with a possible score from 0 to 126 with higher scores indicating a healthier diet.
|
Increased score from baseline Prime Diet Quality Score at 21 days after the Rhubarb root tea
|
Diet choices change measured using the Prime Diet Quality Score
Time Frame: Increased score from baseline Prime Diet Quality Score at 21 days after the senna tea
|
Measured using the Prime Diet Quality Score.
The Prime Diet Quality Score (PDQS) measures intake of the 22 component foods/food groups over the last 30 days with seven possible responses for each component ranging from "once a month or less" to "≥ 2 times/day."
Scores are then summed to create a PDQS total diet quality score with a possible score from 0 to 126 with higher scores indicating a healthier diet.
|
Increased score from baseline Prime Diet Quality Score at 21 days after the senna tea
|
Diet choices change measured using the Prime Diet Quality Score
Time Frame: Increased score from baseline Prime Diet Quality Score at 21 days after the green tea
|
Measured using the Prime Diet Quality Score.
The Prime Diet Quality Score (PDQS) measures intake of the 22 component foods/food groups over the last 30 days with seven possible responses for each component ranging from "once a month or less" to "≥ 2 times/day."
Scores are then summed to create a PDQS total diet quality score with a possible score from 0 to 126 with higher scores indicating a healthier diet.
|
Increased score from baseline Prime Diet Quality Score at 21 days after the green tea
|
Diet choices change measured using the Prime Diet Quality Score
Time Frame: Increased score from the Rhubarb root tea Prime Diet Quality Score at 21 days compared with the senna tea at 21 days
|
Measured using the Prime Diet Quality Score.
The Prime Diet Quality Score (PDQS) measures intake of the 22 component foods/food groups over the last 30 days with seven possible responses for each component ranging from "once a month or less" to "≥ 2 times/day."
Scores are then summed to create a PDQS total diet quality score with a possible score from 0 to 126 with higher scores indicating a healthier diet.
|
Increased score from the Rhubarb root tea Prime Diet Quality Score at 21 days compared with the senna tea at 21 days
|
Diet choices change measured using the Prime Diet Quality Score
Time Frame: Increased score from the Rhubarb root tea Prime Diet Quality Score at 21 days compared with the green tea at 21 days
|
Measured using the Prime Diet Quality Score.
The Prime Diet Quality Score (PDQS) measures intake of the 22 component foods/food groups over the last 30 days with seven possible responses for each component ranging from "once a month or less" to "≥ 2 times/day."
Scores are then summed to create a PDQS total diet quality score with a possible score from 0 to 126 with higher scores indicating a healthier diet.
|
Increased score from the Rhubarb root tea Prime Diet Quality Score at 21 days compared with the green tea at 21 days
|
BMI change measured by weight and height
Time Frame: Decrease score from baseline BMI Score at 21 days after the Rhubarb root tea
|
BMI change measured by weight and height will be combined to report BMI in kg/m^2
|
Decrease score from baseline BMI Score at 21 days after the Rhubarb root tea
|
BMI change measured by weight and height
Time Frame: Decrease score from baseline BMI Score at 21 days after the senna tea
|
BMI change measured by weight and height will be combined to report BMI in kg/m^2
|
Decrease score from baseline BMI Score at 21 days after the senna tea
|
BMI change measured by weight and height
Time Frame: Decrease score from baseline BMI Score at 21 days after the green tea
|
BMI change measured by weight and height will be combined to report BMI in kg/m^2
|
Decrease score from baseline BMI Score at 21 days after the green tea
|
BMI change measured by weight and height
Time Frame: Decreased score from the Rhubarb root tea BMI at 21 days compared with the senna tea at 21 days
|
BMI change measured by weight and height will be combined to report BMI in kg/m^2
|
Decreased score from the Rhubarb root tea BMI at 21 days compared with the senna tea at 21 days
|
BMI change measured by weight and height
Time Frame: Decreased score from the Rhubarb root tea BMI at 21 days compared with the green tea at 21 days
|
BMI change measured by weight and height will be combined to report BMI in kg/m^2
|
Decreased score from the Rhubarb root tea BMI at 21 days compared with the green tea at 21 days
|
Changes in short chain fatty acids concentrations in plasma
Time Frame: Increased concentration of total short chain fatty acids from baseline concentration at 21 days after the Rhubarb root tea
|
Changes in short chain fatty acids concentrations in plasma measured using Gas Chromatography-Flame Ionization Detection
|
Increased concentration of total short chain fatty acids from baseline concentration at 21 days after the Rhubarb root tea
|
Changes in short chain fatty acids concentrations in plasma
Time Frame: Increased concentration of total short chain fatty acids from baseline concentration at 21 days after the senna tea
|
Changes in short chain fatty acids concentrations in plasma measured using Gas Chromatography-Flame Ionization Detection
|
Increased concentration of total short chain fatty acids from baseline concentration at 21 days after the senna tea
|
Changes in short chain fatty acids concentrations in plasma
Time Frame: Increased concentration of total short chain fatty acids from baseline concentration at 21 days after the green tea
|
Changes in short chain fatty acids concentrations in plasma measured using Gas Chromatography-Flame Ionization Detection
|
Increased concentration of total short chain fatty acids from baseline concentration at 21 days after the green tea
|
Changes in short chain fatty acids concentrations in plasma
Time Frame: Increased concentration of total short chain fatty acids after the rhubarb root tea at 21 days compared with the senna tea after 21 days
|
Changes in short chain fatty acids concentrations in plasma measured using Gas Chromatography-Flame Ionization Detection
|
Increased concentration of total short chain fatty acids after the rhubarb root tea at 21 days compared with the senna tea after 21 days
|
Changes in short chain fatty acids concentrations in plasma
Time Frame: Increased concentration of total short chain fatty acids after the rhubarb root tea at 21 days compared with the green tea after 21 days
|
Changes in short chain fatty acids concentrations in plasma measured using Gas Chromatography-Flame Ionization Detection
|
Increased concentration of total short chain fatty acids after the rhubarb root tea at 21 days compared with the green tea after 21 days
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 23306
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on TeTrimTeas welsh Herbal tea with senna
-
Zhejiang UniversityGuizhou Meijiao Co., Ltd, ChinaCompletedCardiovascular Diseases | AlcoholsChina
-
Guy's and St Thomas' NHS Foundation TrustCompleted
-
Unilever R&DAtlantia Food Clinical TrialsCompleted
-
Chang Gung Memorial HospitalNot yet recruiting
-
Taipei Veterans General Hospital, TaiwanRecruiting
-
Otsuka Holdings Co., Ltd.Biofortis Innovation ServicesCompletedHealth Knowledge, Attitudes, PracticeUnited States
-
Coombe Women and Infants University HospitalCompleted
-
Unilever R&DLotus Labs Pvt. Ltd, Bangalore, India; Clumax Diagnostics, Bangalore, India; Quipu...Completed
-
Vejle HospitalCompleted